RT @SyneosHealth: 📰JUST LAUNCHED: 2024 Dealmakers' Intentions Survey. Download to learn more about 2024 expectations of biopharma decision-….

RT @SyneosHealth: The Digital Health Coalition gathered insights from thought leaders offering predictions on what lies ahead in 2024. Our….

RT @SyneosHealth: This @PharmExec article explores the intricate landscape for mergers and acquisitions and strategic partnerships in today….

This @PharmExec article explores the intricate landscape for mergers and acquisitions and strategic partnerships in today’s high-stakes environment. Learn more about biopharma innovation and our insights from the 2024 Dealmakers’ Intentions Survey:

Dive into this @Citeline article featuring our expert's insights from the 2024 Dealmakers' Intentions Survey on the funding environment, M&A and partnering: #SyneosHealth. ft. Neel Patel

The Digital Health Coalition gathered insights from thought leaders offering predictions on what lies ahead in 2024. Our expert shares her perspectives on the noteworthy advancements in pharma sales and marketing that unfolded in 2023. #SyneosHealth

RT @pharmaphorum: #AI and #machinelearning are here to stay. Join us on Monday 5th February at 9am CST, 3pm GMT, 4pm CET for a webinar by @….

RT @Xtalks: 💡 Discover the power of #FSP models for small companies! Join @SyneosHealth's webinar to learn how engaging w/ CROs can enhance….

📰JUST LAUNCHED: 2024 Dealmakers' Intentions Survey. Download to learn more about 2024 expectations of biopharma decision-makers including increased focus on antibody-drug conjugates, #generativeAI products and cell & gene therapies. #SyneosHealth

RT @MentorcliQ: Join us for Global Mentoring Strategy at @SyneosHealth on Wednesday, January 17, 2024 at 9 am EST to hear how Syneos Health….

RT @ACROhealth: The product portfolio of a #biopharma group is often split between assets backed by significant resources and ones that are….

RT @ACROhealth: It's not enough for a #ClinicalTrial team to reach regulatory compliance. They must strive for regulatory excellence, foste….

RT @Mill_All: We’re excited to be joined by Hillary Bochniak, CHRO at @SyneosHealth who will be speaking at our Transformational CHRO Assem….

What steps can businesses take to minimize the risks associated with AI-generated content and ensure responsible and ethical usage? In this @WSJ article, our Chief Information & Digital Officer discusses the growing interest in responsible #AI:

RT @ACROhealth: Key #biotech leaders have come together with @SyneosHealth to share thoughts on the uncharted journey the #ClinicalTrial in….

RT @RareRevolutionM: Raymond Huml is the father of two children with #FSHD and he is also the head of @SyneosHealth #RareDiseaseConsortium.….

How are healthcare firms advancing the interlinked issues of gender parity, health equity and women’s financial status? Learn more from IMD about how organizations like #SyneosHealth are furthering women’s advancement in the workplace: #IMDImpact

RT @ElligoHealth: Today, we announced a new partnership with @SyneosHealth that is expanding access to available Syneos Health trials throu….

📰NEWS: #SyneosHealth appoints Colin Shannon as Chief Executive Officer. Together with Michelle Keefe, who remains on the Board and part of the executive leadership team, they will continue to drive the Company’s ongoing transformation:

RT @PM360online: @SyneosHealth® is a fully integrated biopharmaceutical solutions organization built to accelerate customer success. They'r….